Outcome of acute stroke treatment with intravenous thrombolytic drug in Singburi Hospital

Authors

  • Wipaporn Treesutat กลุ่มงานอายุรกรรม โรงพยาบาลสิงห์บุรี

Keywords:

Acute ischemic stroke, intravenous thrombolysis, good outcome

Abstract

Objectives: To study clinical outcome after treated with intravenous thrombolytic drug in acute ischemic stroke in Singburi Hospital .The secondary objective was to study factor affecting good outcome patients. A retrospective study of data from medical records of patients diagnosed with acute stroke treated with intravenous thrombolytic drugs admitted to Singburi Hospital. During the period from 1 January 2016–30 April 2020, the basic information of the underlying disease is collected. 98 patients who received intravenous thrombosis medications for up to 3 months analyzed the data using descriptive statistics, average, percentage, Mann whitney U Test and logistical regression analysis. Results: Seventy-four patients, age 41-83 years old, an average age 64.0±10.9 years old, good outcome after treated with intravenous thrombolytic drugs was 49 patients (66.2%), An average onset to door time 106.1±49.9 minutes. An average door to needle time 64.4±28.5 minutes. An average onset to needle time 171.0±52.2 minutes. An median NIHSS 8. From the study, factors associated with good outcome were Triglyceride greater than 150 mg/dl and NIHSS at ER <10. Conclusions: Almost outcome of treatement with intravenous thrombolytic drug in acute ischemic stroke is good outcome about 66.2 percent. Factors associated with good outcome were triglyceride greater than 150 mg/dl and NIHSS at ER <10.

Downloads

Download data is not yet available.

References

Feigin VL, Norrving B, Mensah GA. Global Burden of Stroke. Circ Res. 2017;120(3):439-48.

กลุ่มข้อมูลข่าวสารสุขภาพ, กองยุทธศาสตร์และแผนงานสำนักงานปลัดกระทรวงสาธารณสุข, สถิติสาธารณสุข พ.ศ. 2561:77-78.

Truelsen T, Begg S, Mathers C. The global burden of cerebrovascularDisease [Internet]. 2000 [cited 2017 Jun 15]. 1-56. Available from: http://www.who.int/healthinfo/statistics/bod_cerebrovasculardiseasestroke.pdf.

National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–7.

Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.

del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009;40:2945–8.

Jauch EC, Saver JL, Adams HP, et al. guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:870-947.

Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46–e99.

Powers WJ,Ackerson Teri,Bambakidis NC,et al.2019 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019;49:e344–e418.

Lees KR, Bluhmki E, Kummer R von, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooledanalysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-703.

Dharmasaroja PA, Dharmasaroja P, Muengtaweepongsa S. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis. J Neurol Sci 2011;300:74-7.

Downloads

Published

20-08-2024

How to Cite

1.
Treesutat W. Outcome of acute stroke treatment with intravenous thrombolytic drug in Singburi Hospital. Singburi Hosp J [internet]. 2024 Aug. 20 [cited 2026 Jan. 5];29(2):12-24. available from: https://he01.tci-thaijo.org/index.php/shj/article/view/248785